L&S Knock-Out GS7/ DE000LX08V21 /

5/22/2022 6:58:54 PM	Chg.0.000	Bid6:58:54 PM	Ask-	Underlying	Strike price	Expiration date	Option type
0.190EUR	0.00%	0.190 Bid Size: -	- Ask Size: -	GSK PLC L...	22.724 -	12/31/2078	Put

TeleTrader 4/27 GSK's turnover at £9.78B in Q1, up 32% YoY

TeleTrader 3/30 EMA begins reviewing Sanofi-GSK COVID-19 vaccine

GlobeNewswire 3/25 US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...

GlobeNewswire 3/16 Radius Health Announces Leadership Appointments

GlobeNewswire 2/28 Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...

GlobeNewswire 2/28 Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...

GlobeNewswire 2/24 Alector Reports Fourth Quarter and Full Year 2021 Financial Results

TeleTrader 2/23 Sanofi, GSK to ask for COVID-19 vaccine authorization

GlobeNewswire 2/10 Surface Oncology to Participate in Citi's 2022 Virtual Immuno-Oncology Summit

GlobeNewswire 2/10 Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2

TeleTrader 2/9 Europe opens higher with earnings, data in focus

TeleTrader 2/9 GSK: Q4 turnover increases 9% to £9.5B

TeleTrader 2/9 Europe up in premarket ahead of Germany's trade data

TeleTrader 1/17 Unilever says GSK is 'strong fit' after rejected bid

TeleTrader 1/17 Europe opens higher amid the Forum, COVID data

TeleTrader 1/13 GSK, Vir seek approval for vaccine antibody therapy in US

TeleTrader 1/11 US acquires 600,000 new doses of GSK-Vir COVID drug

TeleTrader 12/22/2021 Omicron might behave differently in US - Fauci

TeleTrader 12/16/2021 EMA approves GSK's COVID-19 treatment

TeleTrader 12/15/2021 Sanofi, GSK virus booster shot data in early 2022

GlobeNewswire 12/14/2021 Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...

TeleTrader 12/7/2021 GSK-Vir COVID-19 drug effective vs. Omicron - data

TeleTrader 12/3/2021 Pfizer drug likely to retain effect against Omicron - Fauci

GlobeNewswire 12/2/2021 Surface Oncology to Present New Clinical Data from Ongoing SRF617 Phase 1 Trial at the European Soci...

TeleTrader 12/2/2021 UK approves GSK antibody COVID-19 drug